A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
2018 · Nature Communications · 185 citations
https://doi.org/10.1038/s41467-018-05032-8
W
Weilai Dong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
89
Papers
3.0K
Citations
25
h-index
37
i10-index
Weilai Dong is an academic researcher from Yale New Haven Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Fetal and Pediatric Neurological Disorders. The author has an h-index of 25, co-authored 76 publications.
ORCID: 0000-0002-8376-1758Papers by this author
worksExome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus
2020 · Nature Medicine · 159 citations
https://doi.org/10.1038/s41591-020-1090-2
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy
2019 · Proceedings of the National Academy of Sciences · 93 citations
https://doi.org/10.1073/pnas.1911385116
Exome Sequencing Implicates Impaired GABA Signaling and Neuronal Ion Transport in Trigeminal Neuralgia
2020 · iScience · 46 citations
https://doi.org/10.1016/j.isci.2020.101552
Dual inhibiting OCT4 and AKT potently suppresses the propagation of human cancer cells
2017 · Scientific Reports · 27 citations
https://doi.org/10.1038/srep46246
Mutation of key signaling regulators of cerebrovascular development in vein of Galen malformations
2023 · Nature Communications · 22 citations
https://doi.org/10.1038/s41467-023-43062-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat